Pharmacy Operational Update
MedPal AI plc has reported strong operational performance from its pharmacy subsidiary, MedPal Limited, dispensing nearly 147,000 prescription items and generating over £1.5 million in turnover within its first four months of operation since November 2025. The company achieved an average gross margin of approximately 33%, driven by its efficient, technology-driven model, with February 2026 alone seeing 32,637 items dispensed, contributing to monthly pharmacy revenue exceeding £300,000. This sustained growth highlights the effectiveness of MedPal AI's integrated platform, including its AI triage system and robotic dispensing, and increasing patient demand for both NHS and private prescription services.
Select text to share a quote on X · sign in to keep highlights & notes in your MPAL notes
MedPal AI (AIM: MPAL, FRA: Z1N), the AI-powered, integrated digital health company, is pleased to provide an operational update on pharmacy dispensing volumes at its wholly-owned subsidiary, MedPal Limited.
MedPal AI combines its user-friendly mobile app, AI-driven diagnosis and triage with human-in-the-loop clinical oversight and prescribing services, with high-tech robotic pharmacy dispensing.
Dispensing Performance
Since the launch of pharmacy operations at the Company's national distribution centre in November 2025, MedPal Limited has dispensed a total of almost 147,000 prescription items in the first four months of operations, generating turnover in the period in excess of £1.5 million.
The average gross margin across the period was approximately 33%, reflecting the Company's efficient, technology-driven fulfilment model and favourable unit economics as prescription volumes continue to scale.
In February 2026, the Company dispensed 32,637 items, maintaining a strong level of activity and continuing to support monthly pharmacy revenue in excess of £300,000.
This sustained growth in dispensing volumes further demonstrates the effectiveness of the Company's advanced AI triage system and state-of-the-art robotic dispensing infrastructure, together with increasing patient demand for both NHS and private prescription services, including through the MedPal.clinic weight-loss platform
Jason Drummond, CEO of MedPal AI, said:
"Dispensing nearly 147,000 prescription items and generating turnover in excess of £1.5 million in our first four months of pharmacy operations is an outstanding achievement for the Company. This performance validates the scalability and commercial viability of our automated dispensing model and the strength of our vertically integrated platform.
"We continue to see strong demand across both our NHS Distance Selling Pharmacy contract and our private weight-loss services through MedPal.clinic, and we look forward to updating the market on continued progress."
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.